BNP Paribas maintains Aptiv at Outperform, lowers price target to $59 from $63

BNP Paribas kept Aptiv at Outperform, cutting its price target to $59 from $63. The new target suggests a 42.7% upside from the Nov 3 close of $41.34. Recent analyst targets for Aptiv range from $53 to $64.

Original reporting
Published Nov 4, 2026, 5:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BNP Paribas maintains Aptiv at Outperform, lowers price target to $59 from $63 — source image
Decision brief

The 30-second read

$APTVNeutralLow
01

Why it matters

This is primarily a sentiment and valuation update rather than a fundamental catalyst; it can influence near-term positioning but is unlikely to drive a major repricing alone.

02

Market read

A lower price target with the same Outperform rating can create mixed signals for traders, typically affecting short-term sentiment more than fundamentals.

03

What to watch

Without the analyst’s thesis details, the market may not re-rate the stock materially; the implied upside depends on the Nov 3 close referenced, not on new fundamentals.

Relevance 4/10Novelty 4/10Timing: today, as the analyst note/PT change is newly published

Background

The piece summarizes BNP Paribas’ latest analyst action on Aptiv, including a maintained rating and a reduced price target.

Company-level read

Ticker impact

$APTVNeutralMedium confidence
Context

BNP Paribas maintained Aptiv at Outperform and cut its price target to $59 from $63, implying a large modeled upside from the Nov 3 close.

Expected impact

Likely mild downside or choppy trading as the market digests the lower target, offset by the unchanged Outperform stance.

Evidence & confidence

The article provides only an analyst action (PT change) with no new company fundamentals; direction depends on whether traders focus on the PT reduction or the retained bullish rating.

Market effects

Limited read-through to auto parts/vehicle electronics peers because this is a single-name analyst target change without new sector data.

No clear regional spillover indicated; this is a US-listed single-stock note.

Minimal global relevance beyond sentiment for the auto supply chain.

Counterpoint

Traders may discount the PT cut as incremental and focus on the unchanged Outperform rating, treating the note as net supportive.

Key entities

  • Aptiv

    Auto parts and vehicle technology company covered by BNP Paribas in the note summarized by the article.

Related articles

$APTVMed

Aptiv Earnings Call Signals Growth Amid 2027 Risks

Aptiv PLC reported Q3 revenue of $3.2B, up 2% YoY, with adjusted EBITDA of $567M. EPS fell to $1.42. The company repurchased $230M in stock and expects $650M in buybacks by year-end. Growth in nonautomotive and China exports was offset by automotive revenue declines and software pressure. Aptiv maintained 2026 guidance but warned of 2027 risks.

$APTVHighAI 8/10

Aptiv PLC (APTV) Q3 2026 Earnings Call Highlights: Non-Auto Momentum and Record Bookings

Aptiv PLC (APTV) reported Q3 2026 earnings, highlighting record bookings and non-auto momentum. The company anticipates $700M in input cost inflation for 2027, primarily from memory chips, which will dilute margins. A $250-$300M revenue headwind is expected from two German luxury OEMs due to program roll-offs. Adjusted EBITDA margin declined 140 basis points to 18%. Free cash flow guidance for 2026 was lowered by $25M to $650M.

$APTVHighAI 8/10

What Aptiv (APTV) Said on Its Q3 Earnings Call

Aptiv (APTV) reported Q3 revenue of $3.2B, with automotive down 1% and non-automotive up 11%. Intelligent Systems revenue fell 3%, while Engineered Components rose 6%. Adjusted EBITDA was $567M, down 140 bps YoY. APTV maintained 2023 guidance but narrowed revenue and reduced free cash flow midpoint by $25M to $650M. Q4 revenue is expected at $3.2B, with adjusted EBITDA of $612M. APTV cited inflation, supply-chain risks, and production pressures for 2027 outlook.

$APTVMed

Aptiv 3Q 2026: Revenue $3.2B, Net income $194M, EPS $0.94— 10-Q Summary

Aptiv reported 3Q 2026 revenue of $3.2B, up 2.3% YoY, and net income of $194M, reversing a prior-year loss. EPS was $0.94, compared to a loss of $1.63. Sales grew 2% in the quarter and year-to-date, with volume growth in North America and Asia Pacific. The company completed a spin-off and cited long-term opportunities in software and automation, while noting OEM investment delays and tariff uncertainty.